131 COMPARISON OF RISK ESTIMATES OF FACTORS ASSOCIATED WITH PROSTATE CANCER INCIDENCE AND MORTALITY BETWEEN SCREENED AND CONTROL ARMS IN THE PLCO TRIAL
Amanda Black(St. Elizabeth's Hospital), Gerald Andriole(Barnes-Jewish Hospital), Timothy R. Church(University of Minnesota), Jerome Mabie(Information Management Services), Lawrence R. Ragard(Westat (United States)), Christine D. Berg(Prevention Group), Thomas Hickey(Information Management Services), Robert L. Grubb, David Crawford(University of Colorado Health), Douglas J. Reding(Ascension), Grant Izmirlian(National Institutes of Health), Thomas Riley(National Cancer Institute), Philip C. Prorok(National Cancer Institute)
Cited by 0
Related Papers
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
|New England Journal of Medicine|1993|3.3k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
|New England Journal of Medicine|2013|1.4k
The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer
|New England Journal of Medicine|2000|1.4k
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
|JNCI Journal of the National Cancer Institute|2012|1.1k